Brief: Daré Bioscience Announces Grant To Support Development Of A Novel Non-Hormonal Contraceptive Candidate And Expansion Of Ovaprene Pivotal Study Clinical Trial Sites

Dare Bioscience

13/11/2024 13:04

Nov 13 (Reuters) - Dare Bioscience Inc  DARE.O :
    * DARÉ BIOSCIENCE ANNOUNCES GRANT TO SUPPORT DEVELOPMENT OF
A
NOVEL NON-HORMONAL CONTRACEPTIVE CANDIDATE AND EXPANSION OF
OVAPRENE® PIVOTAL STUDY CLINICAL TRIAL SITES

Source text:  ID:nGNX2B1990 
Further company coverage:  DARE.O 

 ((Reuters.Briefs@thomsonreuters.com;))